ZBBX
geneOn this page
Also known as FLJ23049
Summary
ZBBX (zinc finger B-box domain containing, HGNC:26245) is a protein-coding gene on chromosome 3q26.1, encoding Zinc finger B-box domain-containing protein 1 (A8MT70).
Predicted to enable zinc ion binding activity.
Source: NCBI Gene 79740 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 142 total
- MANE Select transcript:
NM_001199201
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26245 |
| Approved symbol | ZBBX |
| Name | zinc finger B-box domain containing |
| Location | 3q26.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23049 |
| Ensembl gene | ENSG00000169064 |
| Ensembl biotype | protein_coding |
| Entrez | 79740 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 10 protein_coding, 4 nonsense_mediated_decay, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000307529, ENST00000392764, ENST00000392766, ENST00000392767, ENST00000455345, ENST00000464922, ENST00000465071, ENST00000469220, ENST00000473888, ENST00000474464, ENST00000485651, ENST00000492642, ENST00000494898, ENST00000674903, ENST00000675490, ENST00000896195, ENST00000968071
RefSeq mRNA: 4 — MANE Select: NM_001199201
NM_001199201, NM_001199202, NM_001377489, NM_024687
CCDS: CCDS3199, CCDS56295, CCDS56296
Canonical transcript exons
ENST00000675490 — 22 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001137924 | 167298305 | 167298458 |
| ENSE00001137933 | 167305643 | 167305950 |
| ENSE00001137940 | 167313974 | 167314116 |
| ENSE00001137947 | 167315750 | 167315829 |
| ENSE00001204246 | 167288867 | 167288983 |
| ENSE00001266428 | 167282238 | 167282495 |
| ENSE00001266477 | 167317488 | 167317597 |
| ENSE00001513024 | 167373706 | 167373787 |
| ENSE00001513025 | 167379638 | 167379792 |
| ENSE00001594987 | 167360675 | 167360723 |
| ENSE00001646009 | 167359870 | 167359979 |
| ENSE00001683259 | 167327942 | 167328116 |
| ENSE00001684114 | 167365886 | 167365976 |
| ENSE00001695085 | 167350420 | 167350515 |
| ENSE00001739047 | 167322117 | 167322237 |
| ENSE00001780229 | 167333827 | 167333985 |
| ENSE00001871716 | 167380247 | 167380297 |
| ENSE00003489198 | 167372834 | 167372950 |
| ENSE00003542055 | 167368461 | 167368574 |
| ENSE00003598114 | 167242505 | 167242643 |
| ENSE00003671418 | 167317005 | 167317105 |
| ENSE00003900298 | 167239843 | 167240919 |
Expression profiles
Bgee: expression breadth ubiquitous, 146 present calls, max score 99.16.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0810 / max 129.1825, expressed in 245 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 45445 | 0.9383 | 239 |
| 45447 | 0.1102 | 29 |
| 45446 | 0.0325 | 19 |
Top tissues by expression
264 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 99.16 | gold quality |
| bronchial epithelial cell | CL:0002328 | 99.08 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 98.40 | gold quality |
| bronchus | UBERON:0002185 | 97.41 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 94.42 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.79 | gold quality |
| right testis | UBERON:0004534 | 92.40 | gold quality |
| left testis | UBERON:0004533 | 92.34 | gold quality |
| testis | UBERON:0000473 | 89.43 | gold quality |
| sperm | CL:0000019 | 89.32 | gold quality |
| male germ cell | CL:0000015 | 87.27 | gold quality |
| caput epididymis | UBERON:0004358 | 83.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.62 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.35 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 81.31 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 81.05 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 80.51 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 80.25 | gold quality |
| right lung | UBERON:0002167 | 78.95 | gold quality |
| adenohypophysis | UBERON:0002196 | 78.14 | gold quality |
| caudate nucleus | UBERON:0001873 | 77.64 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 77.46 | gold quality |
| cingulate cortex | UBERON:0003027 | 77.36 | gold quality |
| fallopian tube | UBERON:0003889 | 77.01 | gold quality |
| adult organism | UBERON:0007023 | 76.89 | gold quality |
| nucleus accumbens | UBERON:0001882 | 76.61 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 76.51 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 75.77 | gold quality |
| pituitary gland | UBERON:0000007 | 75.65 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 75.29 | silver quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 60.73 |
| E-ANND-3 | yes | 10.70 |
| E-MTAB-9388 | yes | 6.51 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting ZBBX, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-3682-3P | 99.58 | 67.63 | 865 |
| HSA-MIR-18A-3P | 99.56 | 65.68 | 1092 |
| HSA-MIR-105-5P | 99.54 | 69.24 | 2060 |
| HSA-MIR-7853-5P | 99.54 | 69.30 | 2055 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-8064 | 99.45 | 66.92 | 875 |
| HSA-MIR-140-5P | 99.44 | 67.20 | 792 |
| HSA-MIR-4460 | 99.37 | 68.52 | 615 |
| HSA-MIR-3614-5P | 99.30 | 65.25 | 837 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zbbx | ENSMUSG00000034151 |
| rattus_norvegicus | Zbbx | ENSRNOG00000009792 |
Protein
Protein identifiers
Zinc finger B-box domain-containing protein 1 — A8MT70 (reviewed: A8MT70)
All UniProt accessions (7): A8MT70, A0A6Q8PGH4, C9J608, C9JVV2, H7C4M7, H7C534, H7C590
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A8MT70-1 | 1 | yes |
| A8MT70-3 | 3 | |
| A8MT70-2 | 2 |
RefSeq proteins (4): NP_001186130, NP_001186131, NP_001364418, NP_078963 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037688 | ZBBX | Family |
Pfam: PF22586
UniProt features (23 total): sequence variant 8, region of interest 3, sequence conflict 3, compositionally biased region 3, splice variant 2, coiled-coil region 2, chain 1, zinc finger region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MT70-F1 | 50.41 | 0.06 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 67 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, LEE_NEURAL_CREST_STEM_CELL_DN, IVANOVA_HEMATOPOIESIS_MATURE_CELL, chr3q26, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, NOTCH_DN.V1_UP, IL15_UP.V1_UP, FOXJ2_TARGET_GENES, FOXN3_TARGET_GENES, GLI1_TARGET_GENES, UBN1_TARGET_GENES, ZNF146_TARGET_GENES, ZNF257_TARGET_GENES, MIR548D_3P
GO Biological Process (0):
GO Molecular Function (2): zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
472 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBBX | WDR49 | Q8IV35 | 718 |
| ZBBX | GJD4 | Q96KN9 | 524 |
| ZBBX | NRSN2 | Q9GZP1 | 519 |
| ZBBX | FSTL5 | Q8N475 | 472 |
| ZBBX | RGS9BP | Q6ZS82 | 465 |
| ZBBX | SERPINI2 | O75830 | 450 |
| ZBBX | CARMIL3 | Q8ND23 | 447 |
| ZBBX | ASXL3 | Q9C0F0 | 437 |
| ZBBX | VWA3A | A6NCI4 | 435 |
| ZBBX | LRRC46 | Q96FV0 | 418 |
| ZBBX | CFAP52 | Q8N1V2 | 392 |
| ZBBX | CIMIP1 | Q9H1P6 | 391 |
| ZBBX | CNBD1 | Q8NA66 | 391 |
| ZBBX | SORCS3 | Q9UPU3 | 375 |
| ZBBX | ARMCX2 | Q7L311 | 370 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZBBX | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (50): FAT3 (Affinity Capture-MS), AMY1C (Affinity Capture-MS), KIAA0232 (Affinity Capture-MS), FAT4 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), TBC1D17 (Affinity Capture-MS), HERC1 (Affinity Capture-MS), DNM3 (Affinity Capture-MS), CELSR2 (Affinity Capture-MS), HECTD3 (Affinity Capture-MS), FREM2 (Affinity Capture-MS), POLA2 (Affinity Capture-MS), ZZEF1 (Affinity Capture-MS), ZG16B (Affinity Capture-MS), URI1 (Affinity Capture-MS)
ESM2 similar proteins: A0AUZ9, A0JMF7, A1L2Y1, A3KMW7, A8MT70, A8MW92, A9JRX0, B0CM36, B0S6S9, B7ZS37, D3Z987, F1QB81, O95447, P40649, Q0IHW6, Q0P5X5, Q14B48, Q15468, Q3U285, Q3V089, Q49A88, Q4R815, Q4V9H5, Q5CZC0, Q5DTI6, Q5REF4, Q5T1N1, Q5ZJK5, Q66H35, Q6NRH7, Q6NRK3, Q6ZRS4, Q6ZU52, Q80VP2, Q80WQ8, Q8BLG0, Q8CB14, Q8CCJ9, Q8IUR6, Q8IX21
Diamond homologs: A8MT70, Q0P5X5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
142 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 106 |
| Likely benign | 16 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3788 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:167282232:GATTA:G | donor_loss | 1.0000 |
| 3:167282233:ATTAC:A | donor_loss | 1.0000 |
| 3:167282234:TTACC:T | donor_loss | 1.0000 |
| 3:167282235:TAC:T | donor_loss | 1.0000 |
| 3:167282236:AC:A | donor_loss | 1.0000 |
| 3:167282237:C:CA | donor_loss | 1.0000 |
| 3:167282491:CTGAC:C | acceptor_gain | 1.0000 |
| 3:167282492:TGAC:T | acceptor_gain | 1.0000 |
| 3:167282495:CCTAA:C | acceptor_loss | 1.0000 |
| 3:167282496:C:CC | acceptor_gain | 1.0000 |
| 3:167298456:CAA:C | acceptor_gain | 1.0000 |
| 3:167298459:C:CC | acceptor_gain | 1.0000 |
| 3:167305875:T:A | donor_gain | 1.0000 |
| 3:167314121:CACA:C | acceptor_gain | 1.0000 |
| 3:167314123:CA:C | acceptor_gain | 1.0000 |
| 3:167314124:A:AC | acceptor_gain | 1.0000 |
| 3:167314124:A:C | acceptor_gain | 1.0000 |
| 3:167314126:G:GC | acceptor_gain | 1.0000 |
| 3:167315831:T:C | acceptor_gain | 1.0000 |
| 3:167315834:T:TC | acceptor_gain | 1.0000 |
| 3:167316998:CACT:C | donor_loss | 1.0000 |
| 3:167316999:ACTT:A | donor_loss | 1.0000 |
| 3:167317000:CTTA:C | donor_loss | 1.0000 |
| 3:167317001:TTACA:T | donor_loss | 1.0000 |
| 3:167317002:T:TG | donor_loss | 1.0000 |
| 3:167317003:A:AC | donor_gain | 1.0000 |
| 3:167317003:ACA:A | donor_loss | 1.0000 |
| 3:167317004:C:CC | donor_gain | 1.0000 |
| 3:167317004:CAT:C | donor_gain | 1.0000 |
| 3:167317103:CAC:C | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000024565 (3:167212354 C>A,T), RS1000025655 (3:167302798 C>T), RS1000032327 (3:167189718 T>A), RS1000041397 (3:167195673 A>G), RS1000050432 (3:167387003 T>C), RS1000103264 (3:167254709 C>A,T), RS1000117728 (3:167221251 C>T), RS1000128170 (3:167352408 G>A), RS1000136279 (3:167340882 G>A,T), RS1000138079 (3:167393773 T>C), RS1000146587 (3:167239217 G>T), RS1000156442 (3:167297976 C>T), RS1000167664 (3:167310518 G>T), RS1000169035 (3:167278780 G>A,T), RS1000191028 (3:167226565 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004048_1 | Fast beta electroencephalogram | 5.000000e-09 |
| GCST005352_10 | Paclitaxel disposition in epithelial ovarian cancer | 6.000000e-07 |
| GCST005352_6 | Paclitaxel disposition in epithelial ovarian cancer | 5.000000e-07 |
| GCST007743_12 | Iris color (L* coordinate) | 1.000000e-06 |
| GCST010732_13 | Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer | 5.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004357 | electroencephalogram measurement |
| EFO:0009764 | eye colour measurement |
| EFO:0005260 | response to antimicrotubule agent |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 3 |
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| sodium arsenite | affects methylation | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triclosan | increases methylation | 1 |
| Zinc | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): peripheral neuropathy